Minocycline-induced hyperpigmentation

Journal of Family Practice, August, 1995 by Ping-Hsin Hung, James B. Caldwell, William D. James

References

(1.)Filman AG, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. Elmsford, NY: Pergamon Press, 1990.

(2.)Saivin S, Houin G. Clinical pharmacokinetics of doxycycline and minocycline. Clin Pharmacokinet 1988; 15:355-66.

(3.)Basler RSW, Kohnen PW. Localized hemosiderosis as a sequela of acne. Arch Dermatol 1978; 114:1695-7.

(4.)Simons JJ, Morales A. Minocycline and generalized cutaneous pigmentation. J Am Acad Dermatol 1980; 3:244-7.

(5.)Fenske NA, Millns JL, Greer KE. Minocycline-induced pigmentation at sites of cutaneous inflammation. JAMA 1980; 244:1103-6.

(6.)McGrae JD, Zelickson AS. Skin pigmentation secondary to minocycline therapy. Arch Dermatol 1980; 116:1262-5.

(7.)Ridgway HA, Sonnex TS, Kennedy CTC, et al. Hyperpigmentation associated with oral minocycline. Br J Dermatol 1982; 107:95-102.

(8.)Wolfe ID, Reichmister J. Minocycline hyperpigmentation: skin, tooth, nail, and bone involvement. Cutis 1984; 33:457-8.

(9.)Gordon G, Sparano BM, Iatropoulos MJ. Hyperpigmentation of the skin associated with minocycline therapy. Arch Dermatol 1985; 121:618-23.

(10.)Angeloni VL, Salasche SJ, Ortiz R. Nail, skin, and scleral pigmentation induced by minocycline. Cutis 1987; 40:229-33.

(11.)Cale AE, Freedman PD, Lumerman H. Pigmentation of the jawbones and teeth secondary to minocycline hydrochloride therapy. J Periodontol 1988; 59:112-4.

(12.)Okada N, Moriya K, Nishida K, et al. Skin pigmentation associated with minocycline therapy. Br J Dermatol 1989; 121:247-54.

(13.)Eedy DJ, Burrows D. Minocycline-induced pigmentation occurring in two sisters. Clin Exp Dermatol 1991; 16(1):55-7.

(14.)Pepine M, Flowers FP, Ramos-Caro FA, et al. Extensive cutaneous hyperpigmentation caused by minocycline. J Am Acad Dermatol 1993; 28:292-5.

(15.)Brothers DM, Hidayat AA. Conjunctival pigmentation associated with tetracycline medication. Ophthalmology 1981; 88:1212-5.

(16.)Messmer E, Font RL, Sheldon G, et al. Pigmented conjunctival cysts following tetracycline/minocycline therapy. Ophthalmology 1983; 90:1462-8.

(17.)Salman RA, Salman DG, Glickman RS, et al. Minocycline-induced pigmentation of the oral cavity. J Oral Med 1985; 40:154-7.

(18.)Attwood HD, Dennett X. A black thyroid and minocycline treatment. BMJ 1976; 2:1109-10.

(19.)Gordon G, Sparano BM, Kramer AW, et al. Thyroid gland pigmentation and minocycline therapy. Am J Pathol 1984; 117:98-109.

(20.)Alexander CB, Herrara GA, Jaffe K, et al. Black thyroid: clinical manifestations, ultrastructural findings, and possible mechanisms. Hum Pathol 1985; 16:72-8.

(21.)Basler RSW, Lynch PJ. Black galactorrhea as a consequence of minocycline and phenothiazine therapy. Arch Dermatol 1985; 121:417-8.

(22.)Basler RSW. Minocycline-related hyperpigmentation. Arch Dermatol 1985; 121:606-8.

(23.)Poliak SC, DiGiovanna JJ, Gross EG, et al. Minocycline-associated tooth discoloration in young adults. JAMA 1985; 254:2930-2.

(24.)Berger RS, Mandel EB, Hayes TJ, et al. Minocycline staining of the oral cavity. J Am Acad Dermatol 1989; 21:1300-1.